Search

everythinglearnresearchcommunity

for

Search:↓

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

BPH management needs better long-term studies and prevention strategies.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Method can accurately measure five BPH drugs at once.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Yiqi Huayu medicine can effectively reduce BPH in rats by lowering MMP-2 levels and blood vessel growth.

Animal models are crucial for learning about hair loss and finding treatments.

A new method was developed to accurately measure enzyme activity related to prostate health.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

The effectiveness of finasteride for preventing chronic bacterial prostatitis is unclear.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Moose have unique interdigital glands with green hairs and larger glands during mating season.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.